Soft Tissue Repair Market worth $14.7 Billion in 2019

The report “Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Browse 70 market data tables and 32 figures spread through 180 pages and in-depth TOC on “Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019"

Full report : http://www.marketsandmarkets.com/Market-Reports/soft-tissue-repair-devices-market-216009453.html

This report studies the global soft tissue repair market, with forecast to 2019. The soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a healthy CAGR of 7.5% from 2014 to 2019. Growth in this market is attributed to the increasing incidence of soft tissue injuries, increasing healthcare expenditure, lack of substitutes for soft tissue repair surgery, increasing aging population & obesity rate, and geographic expansion by leading players in emerging markets. However, the increasing cost of surgical procedures, the lack of reimbursement, and stringent regulatory requirements are curbing market growth to a certain extent.

The global soft tissue repair market is segmented by product, application, and region. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments.

North America, a major market for global soft tissue repair, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth owing to rising investments by public and private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets.

Key players in this market include LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).

Source : http://gaurav-gujarathi.skyrock.com/3294197180-Soft-Tissue-Repair-Market-worth-14-7-Billion-in-2019.html

Computer Assisted Coding Market | Key Players | Market Overview

The report “Computer Assisted Coding Market by Software (Natural language processing, Structured input, Integrated), by Application (Automated encoding, Management reporting, Clinical code auditing & analytics), & by End User - Global Forecast to 2019 ”

The global computer-assisted coding market is experiencing a high growth during the recent years. CAC solutions are increasingly used to reduce coding errors, increase coder productivity, and offer quality healthcare. This can be attributed to various factors such as rapid growth in the number of healthcare facilities, increasing insurance claim reimbursement, and favorable government in the computer-assisted coding market.

Full Report : http://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html

The mandatory conversion of ICD-9 to ICD-10 in the North American healthcare industry by October 1, 2015 is expected to drive the market growth. This has led to the growing implementation of ICD-10 diagnosis and procedure codes for insurance claim reimbursement, payment billing, and revenue cycle management.

In this report, the computer-assisted coding market is segmented by solution, mode of delivery, application, end user, and geographic regions. It also discusses the key market drivers, restraints, and opportunities of this market and its submarkets. The market is expected to grow at a double-digit CAGR during the forecast period.

In 2013, North America accounted for the largest share of the computer-assisted coding market, followed by Europe and Asia-Pacific. The presence of a large number of computer-assisted coding solution market players in the North American region, developed healthcare IT infrastructure, and technological advancements such as implementation of ICD-10 has led to a large market share of North America in the global computer-assisted coding market. However, the APAC region represents the highest growth opportunity for the computer-assisted coding market during the forecast period. Growing investments by emerging countries such as China, India, and Brazil in the CAC solution sector, rising need for better healthcare, and increasing government initiatives globally are expected to propel the growth of this market

Major players in the computer-assisted coding market include 3M Health Information Systems (U.S.), OptumInsight, Inc. (U.S.), McKesson Corporation (U.S.), Nuance Communications (U.S.), Cerner Corporation (U.S.), Dolbey Systems, Inc. (U.S.), Precyse Solutions LLC (U.S.), Craneware plc (U.S.), Artificial Medical Intelligence (U.S.), and TruCode (U.S.).

Source : Computer Assisted Coding Market

Gas Chromatography Market worth $3,605.1 Million by 2019 - Gaurav-Gujarathi's blog

The report “Gas Chromatography Market by Instrumentation (Systems, Detectors, Autosamplers, Fraction collectors), by Consumables & Accessories (Columns, Fittings & Tubings, Flow Management), by Reagents (Analytical, Preparative) - Analysis & Global forecast to 2019”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the World.

Download PDF Brochure : http://www.marketsandmarkets.com/pdfdownload.asp?id=101656773

Browse 319 market data tables and 41 figures spread through 278 pages and in-depth TOC on “Gas Chromatography Market by Instrumentation (Systems, Detectors, Autosamplers, Fraction collectors), by Consumables & Accessories (Columns, Fittings & Tubings, Flow Management), by Reagents (Analytical, Preparative) - Analysis & Global forecast to 2019”

Full Report : http://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html

This report studies the global gas chromatography market over the forecast period of 2014 to 2019. The market, valued at $2,583.6 million in 2014, is poised to grow at a CAGR of 6.9% from 2014 to 2019 to reach $3,605.1 million by 2019.

The global gas chromatography market is categorized into three broad segments, namely, Instrumentation, Accessories & Consumables and Reagents. The Instrumentation market comprises of Systems, Detectors, Auto Samplers and Fraction Collectors. The gas chromatography detectors are further categorized into flame ionization detectors, mass detectors, thermal conductivity detectors, and others. The market for gas chromatography Accessories & Consumables is segmented into Columns, Column Accessories, Autosampler Accessories, Flow Management Consumables & Accessories, Fittings & Tubing, Mobile Phase Accessories, Pressure Regulators, and Others. The gas chromatography reagents market comprises of Analytical reagents and Preparative reagents.

The increased importance of chromatography tests in drug approvals is likely to drive the growth of this market. Biotechnology and pharmaceutical industries are the prime users of the chromatography technique. Furthermore, government bodies have extended their help in the form of investments, funds, and grants, which has stimulated the usage of advanced chromatographic techniques in these industries. Tie-ups with research laboratories and academic institutes have resulted in increased support for research. Research activities in the fields of medicine, proteomics, metabolomics, and genomics are also increasing the use of chromatography instruments in these industries. A number of factors such as technological advancements, new product launches, and rise in the number of conferences related to chromatography technologies are propelling the growth of the chromatography instrumentation market.

North America accounts for the largest share of the gas chromatography market, mainly due to augmented research activities for drug and biologic development, chromatography conferences, and direct and indirect government investments in the chromatography market. The Asian market is expected to witness high growth in the forecast period. A number of factors such as the increasing number of conferences on chromatography in Singapore and Malaysia; expansion of chromatography companies in China, India, Singapore, Vietnam, and Japan; and prominent pharmaceutical companies outsourcing their drug discovery and development services to the Asian region (especially in China and India) are propelling the demand for separation services and thus gas chromatography in Asia.

The major players in the gas chromatography market include Agilent Technologies (U.S.), PerkinElmer (U.S.), Phenomenex, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and W.R. Grace & Co. (U.S.).

Source : Gas Chromatography Market worth $3,605.1 Million by 2019 - Gaurav-Gujarathi's blog

Medical Connectors Market worth 2.69 Billion USD by 2021

The report "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021", report provides a detailed overview of the major drivers, restraints, trends, opportunities, and strategies impacting the medical connectors market along with the estimates and forecasts of the revenue and market share analysis.

Browse 65 market data tables and 42 figures spread through 132 pages and in-depth TOC on "Medical Connectors Market by Product (Flat Silicone, Hybrid, Embedded, Radio Frequency, Push-Pull), Application (Patient Monitoring, Electrosurgery, Endoscopy, Diagnostic Imaging, Respiratory, Dental Device) & by End User - Global Forecast to 2021"

Full Report @ http://www.marketsandmarkets.com/Market-Reports/medical-connector-market-81731061.html

The medical connectors market is projected to reach USD 2.69 Billion by 2021 from USD 1.63 Billion in 2016, at a CAGR of 10.5%. The major factors driving the growth of this market are increasing incidence and prevalence of chronic diseases, rapid growth in the medical devices market, and growth in the home healthcare market, which results in increased adoption of miniaturized connectors and growing healthcare expenditure across the globe.

The medical connectors market is segmented based on products, application, end user, and region in this report. On the basis of products, the market is segmented into flat surgical silicone cables, embedded electronics connectors, radio-frequency connectors, disposable plastic connectors, hybrid circular connectors & receptacle system, power cords with retention system, lighted hospital-grade cords, magnetic medical connectors, and push-pull connectors. The flat surgical silicone cables segment is expected to grow at the highest CAGR during the forecast period. Increasing awareness about the application of connectors and its technical features are the factors driving the growth of this segment.

By application, the market is classified into cardiology devices, diagnostic imaging devices, electrosurgical instruments, patient monitoring devices, endoscopy devices, respiratory devices, analyzers and processing instruments, dental instruments, neurology devices, enteral devices, and other applications. The patient monitoring devices segment is expected to grow at the highest CAGR during the forecast period due to increasing incidence of chronic diseases and increasing adoption of patient monitoring devices.

Based on end user, the market is classified into hospitals & clinics, diagnostic laboratories and imaging centers, ambulatory surgical centers, and other end users. The hospitals & clinics end user segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing demand for electrosurgical therapy and growing incidence of chronic disorders.

On the basis of region, North America accounted for the largest share in the market in 2016. However, in the coming five years, growth in the market is expected to be centered on Asia. The increasing prevalence and incidence rate of chronic disorders in Asia provides growth opportunities to players in the market. Key players are focusing on strategies such as product launches, acquisitions, and expansions to strengthen their foothold in the market.

Key players in the market include Amphenol Corporation (U.S.), Delphi Automotive LLP. (U.K.), Esterline Corporation (U.S.), ITT Corporation (U.S.), Smiths Interconnect (U.K.), TE Connectivity Ltd. (Switzerland), Fisher Connectors (Switzerland), Lemo S.A. (Switzerland), Molex (U.S.), and Samtec (U.S.).

Fetal Monitoring Market worth $2.3 Billion by 2019

The report “Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the fetal monitoring market along with the estimates and forecasts of the revenue and market share analysis.

Browse 188 market data tables and 55 figures spread through 270 pages and in-depth TOC on “Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019"

Full Report @  http://www.marketsandmarkets.com/Market-Reports/fetal-monitoring-market-35700261.html

The global fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8% from 2014 to 2019.

The report segments this market based on products, portability, methods, applications, and end users. Among various end users, the hospitals segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. The high growth in this segment can be attributed to the rising rate of maternal mortality and fetal birth defects, and increasing number of initiatives taken by government organizations for improving prenatal care.
Based on geography, the global fetal monitoring market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this geographic segment is driven by factors such as increasing government support for enhanced maternal facilities and rising company investments for the development of new products.


Key players in the fetal monitoring market include Analogic Corporation (U.S.), ArjoHuntleigh, Inc. (U.S.), Covidien PLC (U.S.), FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), and Spacelabs Healthcare Inc. (U.S.).

Related Articles:

LinkedIn : FetalMonitoring Market worth $2.3 Billion by 2019

WordPress: FetalMonitoring Market worth $2.3 Billion by 2019

Infectious Disease Diagnostics Market worth $18,156.2 Million by 2019

The report "Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019" provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue.

Browse 97 market data tables and 35 figures spread through 180 pages and in-depth TOC on “Infectious Disease Diagnostics Market by Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospital, Laboratories) - Global Forecast to 2019 ”

Full Report @ http://www.marketsandmarkets.com/pdfdownload.asp?id=116764589

The IDD market is poised to reach $18,156.2 million by 2019 from $12,422.8 million in 2014, at a CAGR of 7.9% from 2014 to 2019.

Factors such as high prevalence rate of infectious diseases, increased demand for rapid diagnostic techniques due to slow turnaround time of current techniques, and the increase in government funding are driving market growth. However, rising healthcare costs and a complex regulatory framework are restraining the growth of the global IDD market.

On the basis of products, the IDD market is segmented into instruments and analyzers, consumables (assays and reagents), and software & services. Consumables accounted for the largest share 70% of the global IDD market in 2014.

On the basis of applications, the IDD market is subsegmented into Hepatitis B, Hepatitis C, Acquired Immunodeficiency Syndrome (AIDS), Tuberculosis (TB), Chlamydia Trachomatis and Gonorrhea, Human Papillomavirus (HPV), Methicillin-resistant Staphylococcus aureus (MRSA), and others.

On the basis of technology, the segment is divided into traditional and molecular diagnostics. Traditional methods are categorized into immunodiagnostics, microscopy, and biochemical characterization. The molecular diagnostics segment is further divided into Polymerase Chain Reaction (PCR), INAAT (Isothermal Nucleic Acid Amplification Test), Hybridization, DNA Sequencing & NGS, microarrays, and others (electrophoresis, mass spectrometry, and flow cytometry). Microarrays and INAAT are expected to be the fastest-growing markets in the forecast period. This remarkable growth is attributed to the specificity and increased efficiency of these tests.

On the basis of end-users, the market is segmented into hospital laboratories, reference labs, physician’s office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care, self-testing). Hospital laboratories formed the major end-users of the IDD market in 2014.

On the basis of region, the IDD market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2014, North America accounted for the largest share of the IDD market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure. The growth of the IDD market in Asia-Pacific will revolve around China, India, Australia, and New Zealand. Countries in the Middle East will also show growth.

Major players in this market are Roche Diagnostics (Switzerland), bioMérieux SA (Craponne, France), Thermo Fischer Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories (U.S.), and Becton, Dickinson & Company (U.S.).

Related Articles:

LinkedIn: Infectious Disease Diagnostics Market worth $18,156.2 Million by 2019

WordPress : Infectious Disease Diagnostics Market worth $18,156.2 Million by 2019